Autolus Therapeutics plc
AUTL· Nasdaq
AUTLAutolus Therapeutics plc
Filed Mar 21, 2024 · 10-K · 81 days after period end · 0001730463-24-000048
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $309.00K |
| Net Income | -$77.17M | -$26.95M | -$42.86M | -$40.94M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Autolus Therapeutics plc · CIK 1730463 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Mar 21, 2024 · 81 d after period end
